Sanofi-Aventis S.A. ADR (SNY)

Jun 2, 2025, 11:46 AM EDT - 1 day ago

Sanofi-Blueprint deal is a bullish signal about biotech M&A

Jun 2, 2025, 7:00 AM EDT - 1 day ago

Recludix Pharma Announces Development Candidate Nomination of First-in-Class Oral STAT6 Inhibitor for Inflammatory Diseases and Achievement of Significant Milestone Under Collaboration with Sanofi

Jun 2, 2025, 1:25 AM EDT - 1 day ago

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology

Jun 2, 2025, 1:24 AM EDT - 1 day ago

Sanofi buys US biopharma group Blueprint in $9.1 bln deal

Jun 2, 2025, 1:22 AM EDT - 1 day ago

Sanofi to Acquire Blueprint Medicines for Up to $9.5 Billion

Jun 2, 2025, 1:00 AM EDT - 1 day ago

Press Release: Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology

May 31, 2025, 9:15 AM EDT - 3 days ago

Sanofi: Finding Value In The Wake Of Itepekimab's Disappointment

May 30, 2025, 2:10 PM EDT - 3 days ago

Itepekimab Failure A Setback For Sanofi And Regeneron

May 30, 2025, 3:19 AM EDT - 4 days ago

Sanofi, Regeneron's Itepekimab Delivers Mixed Results in Late-Stage Trials

May 29, 2025, 8:30 AM EDT - 5 days ago

Press Release: Beyfortus public health advantage bolstered by first real-world comparison of infant vs maternal RSV immunization programs

May 27, 2025, 7:37 AM EDT - 7 days ago

US FDA approves use of Sanofi's meningococcal vaccine in infants

May 27, 2025, 3:00 AM EDT - 7 days ago

C4X Discovery receives latest milestone payment from Sanofi

May 27, 2025, 2:17 AM EDT - 7 days ago

Sanofi, VNVC launch vaccine factory in Vietnam

May 27, 2025, 1:00 AM EDT - 7 days ago

Press Release: Sanofi completes acquisition of DR-0201

May 22, 2025, 6:43 PM EDT - 11 days ago

VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc. - VIGL

May 22, 2025, 5:30 PM EDT - 11 days ago

Sanofi opens new, $130 million NJ offices in Morristown, showcasing innovative, modern design and strengthening US presence

May 21, 2025, 7:59 PM EDT - 12 days ago

Sanofi to Buy Vigil Neuroscience for About $470 Million

May 21, 2025, 7:30 PM EDT - 12 days ago

Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi

May 21, 2025, 7:29 PM EDT - 12 days ago

Sanofi to acquire Vigil Neuroscience in $470 million deal

May 21, 2025, 7:15 PM EDT - 12 days ago

Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer's disease to the neurology pipeline

May 20, 2025, 7:30 AM EDT - 14 days ago

Viz.ai Announces Collaboration With Sanofi and Regeneron to Improve Management and Care of Chronic Obstructive Pulmonary Disease (COPD)

May 15, 2025, 12:55 PM EDT - 18 days ago

French finance minister criticises Sanofi's $20 bln USA investment decision

May 14, 2025, 3:58 PM EDT - 19 days ago

Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030

May 14, 2025, 12:42 PM EDT - 19 days ago

Sanofi to invest at least $20 billion in the US through 2030

May 14, 2025, 12:30 PM EDT - 19 days ago

Sanofi to invest at least $20 billion in the US through 2030, growing investments in science and expanding domestic manufacturing

May 9, 2025, 8:35 PM EDT - 24 days ago

Hawaii in $700 million settlement with Bristol-Myers, Sanofi over Plavix warning label

BMY

May 9, 2025, 4:51 PM EDT - 24 days ago

Pharma Worries Shift to Prices From Trade. Trump's Next Plan Could Sink Stocks.

JNJ NVO NVS

May 8, 2025, 7:23 PM EDT - 25 days ago

Pressure is still on the pharma sector, says Mizuho's Jared Holz

ABBV AMGN BMY GILD JNJ LLY MRK

May 6, 2025, 7:08 AM EDT - 4 weeks ago

Sanofi: Investing in prevention builds Europe's health and competitiveness

Apr 30, 2025, 12:46 PM EDT - 4 weeks ago

Press Release: Annual General Meeting of April 30, 2025

Apr 30, 2025, 7:00 AM EDT - 4 weeks ago

Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader

Apr 29, 2025, 7:00 AM EDT - 5 weeks ago

Press Release: When every second counts: Sanofi, McLaren Racing and United Autosports join forces to raise meningitis awareness at Le Mans 24 Hours race

Apr 24, 2025, 2:03 PM EDT - 5 weeks ago

Sanofi (SNY) Q1 2025 Earnings Call Transcript

Apr 24, 2025, 4:48 AM EDT - 5 weeks ago

Sanofi Sales, Profit Beat Expectations on Higher Demand for Skin, Asthma Drug

Apr 24, 2025, 1:33 AM EDT - 5 weeks ago

Sanofi's quarterly profit beats estimates on Dupixent boost, newer products

Apr 24, 2025, 1:30 AM EDT - 5 weeks ago

Press Release: Sanofi: strong Q1 performance and 2025 guidance confirmed

Apr 23, 2025, 2:44 AM EDT - 5 weeks ago

Novartis and Sanofi CEOs say EU should raise drug prices in face of tariffs

NVS

Apr 18, 2025, 11:31 AM EDT - 6 weeks ago

Sanofi-Regeneron's Dupixent gets FDA's nod for skin condition

Apr 18, 2025, 11:15 AM EDT - 6 weeks ago

Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria